Bright Minds Biosciences Inc. (DRUG) vs NeuroPace, Inc. (NPCE)
A side-by-side comparison of Bright Minds Biosciences Inc. and NeuroPace, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DRUG
Bright Minds Biosciences Inc.
$48.56HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
NPCE
NeuroPace, Inc.
$13.06HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — DRUG vs NPCE
growth of $100 · dividends reinvested · last 5yDRUG +107.2% (+15.7%/yr)NPCE -47.0% (-11.9%/yr)DRUG compounded faster over this window
DRUG NPCE
DRUG vs NPCE: by the numbers
- •DRUG is the larger company ($475M vs $445M market cap).
- •Both run net losses; DRUG's is the smaller (0.00% vs -19.34% net margin).
Metrics side by side
Valuation
| Metric | DRUG | NPCE |
|---|---|---|
| P/S ratio | N/A | 4.50 |
| P/B ratio | 2.19 | 37.46 |
Profitability
| Metric | DRUG | NPCE |
|---|---|---|
| Gross margin | 0.00% | 79.63% |
| Operating margin | 0.00% | -15.26% |
| Net margin | 0.00% | -19.34% |
| ROE | -8.21% | -160.85% |
| ROIC | -13.15% | -18.95% |
Growth (annualized)
| Metric | DRUG | NPCE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 15.85% |
| Total return CAGR (5Y) | 6.76% | -4.94% |
Frequently asked
- How have DRUG and NPCE total returns compared?
- Over the past 5 years, DRUG delivered 6.76% and NPCE delivered -4.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bright Minds Biosciences ROENeuroPace ROEBright Minds Biosciences operating marginNeuroPace operating marginBright Minds Biosciences revenue growthNeuroPace revenue growthBright Minds Biosciences free cash flowNeuroPace free cash flow
Bright Minds Biosciences & NeuroPace appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.